JMP Securities reiterated coverage on Evelo Biosciences with a new price target

11/2/21 7:54:09 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $EVLO alert in real time by email

JMP Securities reiterated coverage of Evelo Biosciences with a rating of Market Outperform and set a new price target of $41.50 from $44.00 previously

Get the next $EVLO alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$EVLO

Date	Price Target	Rating	Analyst
11/2/2021	$44.00 → $41.50	Market Outperform	JMP Securities
11/1/2021	$12.00	Neutral → Buy	Chardan Capital Markets
6/23/2021	$36.00 → $38.00	Market Outperform	JMP Securities
6/23/2021	$28.00	Overweight	Cantor Fitzgerald

More analyst ratings

JMP Securities reiterated coverage on Evelo Biosciences with a new price target

Chat with this insight

Recent Analyst Ratings for $EVLO

Recent Analyst Ratings for
$EVLO